Asset Dedication’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $124 | Sell |
3
-11
| -79% | -$478 | ﹤0.01% | 1165 |
|
|
2026
Q2 | $598 | Buy |
14
+8
| +133% | +$357 | ﹤0.01% | 1147 |
|
|
2026
Q1 | $290 | Sell |
6
-1,806
| -100% | -$84.2K | ﹤0.01% | 1073 |
|
|
2025
Q4 | $87.8K | Sell |
1,812
-3
| -0.2% | -$149 | 0.01% | 414 |
|
|
2025
Q3 | $85.7K | Hold |
1,815
| – | – | 0.01% | 442 |
|
|
2025
Q2 | $87.7K | Buy |
1,815
+579
| +47% | +$29.6K | 0.01% | 428 |
|
|
2025
Q1 | $68.5K | Sell |
1,236
-12
| -1% | -$650 | 0.01% | 428 |
|
|
2024
Q4 | $60.2K | Sell |
1,248
-2,654
| -68% | -$135K | ﹤0.01% | 451 |
|
|
2024
Q3 | $225K | Buy |
3,902
+2,886
| +284% | +$156K | 0.02% | 315 |
|
|
2024
Q2 | $49.3K | Sell |
1,016
-280
| -22% | -$13.5K | ﹤0.01% | 499 |
|
|
2024
Q1 | $63K | Buy |
1,296
+282
| +28% | +$13.8K | ﹤0.01% | 417 |
|
|
2023
Q4 | $50K | Buy |
1,014
+67
| +7% | +$3.28K | ﹤0.01% | 431 |
|
|
2023
Q3 | $51K | Buy |
947
+672
| +244% | +$35.8K | ﹤0.01% | 427 |
|
|
2023
Q2 | $15K | Sell |
275
-1
| -0.4% | -$54 | ﹤0.01% | 612 |
|
|
2023
Q1 | $15K | Sell |
276
-461
| -63% | -$22.4K | ﹤0.01% | 608 |
|
|
2022
Q4 | $36K | Hold |
737
| – | – | ﹤0.01% | 462 |
|
|
2022
Q3 | $28K | Sell |
737
-20,028
| -96% | -$892K | ﹤0.01% | 474 |
|
|
2022
Q2 | $1.04M | Sell |
20,765
-485
| -2% | -$25.7K | 0.15% | 88 |
|
|
2022
Q1 | $1.09M | Buy |
21,250
+1,585
| +8% | +$81.8K | 0.12% | 144 |
|
|
2021
Q4 | $983K | Buy |
19,665
+1,833
| +10% | +$90.7K | 0.12% | 139 |
|
|
2021
Q3 | $855K | Sell |
17,832
-465
| -3% | -$23.6K | 0.11% | 141 |
|
|
2021
Q2 | $964K | Buy |
18,297
+6,061
| +50% | +$316K | 0.14% | 125 |
|
|
2021
Q1 | $607K | Buy |
12,236
+2,234
| +22% | +$107K | 0.14% | 138 |
|
|
2020
Q4 | $486K | Buy |
10,002
+6,061
| +154% | +$299K | 0.1% | 159 |
|
|
2020
Q3 | $196K | Buy |
3,941
+865
| +28% | +$44.5K | 0.04% | 228 |
|
|
2020
Q2 | $158K | Buy |
3,076
+58
| +2% | +$2.82K | 0.04% | 223 |
|
|
2020
Q1 | $132K | Buy |
3,018
+1,303
| +76% | +$62.3K | 0.04% | 227 |
|
|
2019
Q4 | $85K | Buy |
1,715
+378
| +28% | +$17.7K | 0.02% | 254 |
|
|
2019
Q3 | $63K | Buy |
+1,337
| New | +$57.7K | 0.02% | 266 |
|
|
2018
Q3 | – | Sell |
-1
| Closed | – | – | 753 |
|
|
2018
Q2 | $0 | Buy |
+1
| New | +$39 | ﹤0.01% | 734 |
|
Other funds holding SNY
Asset Dedication's SNY Position: Q3 2026 in Review
Asset Dedication reduced its Sanofi (SNY) stake by 79% in Q3 2026, selling an estimated $478 and leaving 3 shares worth $124. The position accounts for ﹤0.01% of the portfolio, ranked #1165.
Asset Dedication first reported a position in SNY in Q2 2018 and has held it in 30 quarters since. The position peaked at $1.09M in Q1 2022. 577 funds tracked by Wall St. Rank hold SNY as of Q3 2026.
- Asset Dedication held 3 shares of Sanofi worth $124 as of Q3 2026.
- Asset Dedication sold 11 Sanofi shares in Q3 2026, an estimated $478.
- Sanofi made up ﹤0.01% of Asset Dedication's portfolio in Q3 2026, its #1165 holding.
- Asset Dedication first reported a position in Sanofi in Q2 2018 and has held it in 30 quarters since.
- Asset Dedication's Sanofi position peaked at $1.09M in Q1 2022.
- 577 funds tracked by Wall St. Rank held Sanofi as of Q3 2026.
Based on Asset Dedication's 13F filing for Q3 2026, filed 3 Nov 2026.